Archive
Past newsletters of MDDR.
Loading the archive
Past newsletters of MDDR.
Past newsletters of MDDR.
Tuesday, 18 August 2026
The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended expanding triptorelin's PBS listing to include several women's health
Monday, 17 August 2026
Afghanistan's health system is under increasing strain due to restrictions on women and girls, significant cuts to international aid, closur
Sunday, 16 August 2026
Dr. Claire Arundell has been announced as the next President of the Australian College of Rural and Remote Medicine (ACRRM), set to official
Saturday, 15 August 2026
Eli Lilly confirmed its ongoing interest in listing the weight loss drug tirzepatide, marketed as Mounjaro, on Australia's Pharmaceutical Be
Friday, 14 August 2026
The Generic and Biosimilar Medicines Association (GBMA) released a white paper advocating for urgent reforms to enhance Australia's medicine
Thursday, 13 August 2026
Australia’s Health Minister provided an update on negotiations for PBS listing of GLP-1 medications, crucial for obesity management. The gov
Wednesday, 12 August 2026
The Medical Board of Australia has endorsed the Australian Medical Council’s accreditation of Rural Generalist training programs by the RACG
Tuesday, 11 August 2026
The RACGP has endorsed updated guidelines for early detection of clinically significant prostate cancer, marking the first major update in a
Monday, 10 August 2026
Uganda has successfully brought Bundibugyo virus transmission under control, marking the end of its Ebola outbreak. This development comes a
Sunday, 9 August 2026
More than 2,000 patients have received Revolution Medicines’ pancreatic cancer drug daraxonrasib through a compassionate use program, indica